Impact of the COVID-19 pandemic in a cohort of anticoagulant users: a descriptive drug utilization study based on data from the Tuscany Healthcare administrative database

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/37319
• EU PAS number:
  EUPAS37318
• Study ID:
  37319
• Official title and acronym:
  Impact of the COVID-19 pandemic in a cohort of anticoagulant users: a descriptive drug utilization study based on data from the Tuscany Healthcare administrative database
• DARWIN EU® study:
  No
• Study countries:
  Italy
• Study description:
  The rapid spread all over the world of the SARS-COV-2 forced all healthcare professionals to urgently reconsider the management of patients requiring continuing access to healthcare services such as patients treated with anticoagulants. Little is know on the impact of COVID-19 pandemic in the management of patients under anticoagulants treatment. Therefore, the aim of this study is to describe the use of anticoagulants in a large sample of the Italian population. For this purpose, electronic health records of Tuscany will be analyzed.
• Study status:
  Planned

Research institutions and networks

Institutions

University of Milano Bicocca

Study timelines

Date when funding contract was signed

Actual: 27/07/2020

Study start date

Planned: 01/10/2020

Date of final study report

Planned: 21/12/2020

Sources of funding

Other

More details on funding

This is an independent study based on a spontaneous initiative of the participanting partners

Study protocol

Initial protocol

PU_COVID_VKA_DOAC_full_protocol

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable